Foreign Territory: Dietary Supplement Clinical Trials Conducted Abroad
Nutritional Outlook
April 2012
The Federal Trade Commission ("FTC"), in the last couple of years, has made clear that it expects advertisers making strong cause-and-effect claims (e.g., “Lose weight,” “Helps prevent irregularity”) to possess, at a minimum, at least one well-designed and reliable clinical study. Yet, at the same time, FTC staff—those who conduct FTC investigations—have made statements that suggest a growing skepticism of clinical trials conducted abroad.

An article co-authored by partner John Villafranco, published in Nutritional Outlook, "Foreign Territory: Dietary Supplement Clinical Trials Conducted Abroad," discusses this dilemma and provides practical pointers on minimizing risk, whether a company seeks to commission a trial abroad or rely on an existing study for claims.